Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1822]
News [2727]
Articles [201]
Editorials [1]
Conferences [136]
elearning [13]
Investigating anticarcinogenic compounds as an alternative to chemo
Dr Bernardo Bonnani - European Institute of Oncology, Milan, Italy
Investigating anticarcinogenic compounds as an alternative to chemo ( Dr Bernardo Bonnani - European Institute of Oncology, Milan, Italy )
6 Jun 2014
ASCO 2014 roundup
Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
ASCO 2014 roundup ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
2 Jun 2014
Comment: Advances in breast cancer presented at ASCO 2014
Prof Jacek Jassem - Gdańsk Medical University, Gdańsk, Poland
Comment: Advances in breast cancer presented at ASCO 2014 ( Prof Jacek Jassem - Gdańsk Medical University, Gdańsk, Poland )
1 Jun 2014
Comment: Advances in lung cancer presented at ASCO 2014
Prof Jacek Jassem - Gdańsk Medical University, Gdańsk, Poland
Comment: Advances in lung cancer presented at ASCO 2014 ( Prof Jacek Jassem - Gdańsk Medical University, Gdańsk, Poland )
1 Jun 2014
Medyczne nowości w raku gruczołu krokowego
Prof Piotr Jan Wysocki - Poznan University of Medical Sciences, Poznan, Poland
Medyczne nowości w raku gruczołu krokowego ( Prof Piotr Jan Wysocki - Poznan University of Medical Sciences, Poznan, Poland )
1 Jun 2014
The 1st Immunotherapy of Cancer Conference (ITOC)
Prof Heinz Zwierina - Innsbruck Medical University, Innsbruck, Austria
The 1st Immunotherapy of Cancer Conference (ITOC) ( Prof Heinz Zwierina - Innsbruck Medical University, Innsbruck, Austria )
25 Mar 2014
Molecular pathways associated with immune modulation and thalidomide analogues
Dr Rajesh Chopra - Vice President of Translational and Early Drug Development...
Molecular pathways associated with immune modulation and thalidomide analogues ( Dr Rajesh Chopra - Vice President of Translational and Early Drug Development, Celgene )
25 Mar 2014
Novel CEA-targeted IL2 variant immunocytokine for immunotherapy of cancer
Dr Christian Klein - Head of Oncology Programs, Discovery Oncology, Roche...
Novel CEA-targeted IL2 variant immunocytokine for immunotherapy of cancer ( Dr Christian Klein - Head of Oncology Programs, Discovery Oncology, Roche Pharma Research and Early Development, Roche Glycart AG, Schlieren, Switzerland )
24 Mar 2014
PSA as a marker of disease in patients with prostate cancer and bone metastases
Prof Laurence Koltz, Prof Wolfgang Horninger, Prof Bertrand Tombal
PSA as a marker of disease in patients with prostate cancer and bone metastases ( Prof Laurence Koltz, Prof Wolfgang Horninger, Prof Bertrand Tombal )
28 Feb 2014
ecancermedicalscience Editor's Choice for January 2014
Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
ecancermedicalscience Editor's Choice for January 2014 ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
12 Feb 2014
Multiple Myeloma Debate 2014: Recent advances in multiple myeloma
Dr Pieter Sonneveld, Prof Michele Cavo, Dr Jesus San Miguel and Dr Meletios...
Multiple Myeloma Debate 2014: Recent advances in multiple myeloma ( Dr Pieter Sonneveld, Prof Michele Cavo, Dr Jesus San Miguel and Dr Meletios Dimopoulos )
2 Feb 2014
Critical insights on leukaemia and lymphoma from ASH 2013
Prof Robin Foa, Dr Simon Rule, Dr Clemens Wendtner
Critical insights on leukaemia and lymphoma from ASH 2013 ( Prof Robin Foa, Dr Simon Rule, Dr Clemens Wendtner )
2 Feb 2014

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation